REG - Dr. Martens PLC - Confirmation of new CEO start date

Dr MartensAnnouncement

28/11/2024 07:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241128:nRSb9261Na&default-theme=true

RNS Number : 9261N  Dr. Martens PLC  28 November 2024

 

28 November 2024

Dr. Martens plc

('Dr. Martens', 'the Company')

Confirmation of new CEO start date

 

Further to the Company's previous announcement on 16 April 2024 that Ije
Nwokorie would succeed Kenny Wilson as its new Chief Executive Officer before
the end of FY25, Dr. Martens is pleased to announce that Ije's appointment
will take effect from 6 January 2025. The Company also confirms that Kenny
Wilson will step down from the Board on that date. Kenny will remain available
to Ije and the wider Global Leadership Team until 31 March 2025 to ensure a
smooth handover.

In accordance with the Company's statutory obligations under section 430(2B)
Companies Act 2006, details of Kenny Wilson's exit arrangements will be made
available on the Company's corporate website, www.drmartensplc.com
(http://www.drmartensplc.com) .

 

 

This announcement has been made in accordance with the requirements of
paragraph 9.6.12 of the UK Listing Rules. The Company confirms that there is
no further information required to be disclosed pursuant to paragraph 9.6.13
of the UK Listing Rules.

Enquiries

Investors and analysts
 

Bethany Barnes, Director of Investor Relations
                           Bethany.Barnes@drmartens.com
 
 
 
       +44 7825 187465

Beth Fionda, Investor Relations Manager
                                 Beth.Fionda@drmartens.com
 
 
 
                   +44 203 995 2644

 

Press
 

H/Advisors
Maitland
 
+44 207 379 5151

Katharine
Spence
 
+44 7384 535739

 

Gill Hammond, Director of Communications
                                        +44 7384 214248

 

About Dr. Martens

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire.
Produced originally for workers looking for tough, durable boots, the brand
was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens has since transcended its working-class roots while
still celebrating its proud heritage and, six decades later, "Docs" or "DM's"
are worn by people around the world who use them as a symbol of empowerment
and their own individual attitude. The Company is a constituent of the FTSE
250 index.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAEAXFXALPLFFA